|
|
Office Locations:
|
345 California Street, Suite 3300
San Francisco, CA 94104
Phone: 415-743-1500
Fax: 415-743-1501
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
TPG Biotech is the life science venture investment arm of TPG (see profile), a global private investment firm. TPG Biotech invests across life science sectors, geographies, company stages, and asset classes. Since 2002, the firm has invested over half a billion dollars in over forty life science businesses, spanning drug discovery, personalized diagnostic solutions, pharmaceutical services, medical devices, and industrial biotechnology. TPG Biotech has approximately $910 million in assets currently under management.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
